Trial
NCT03611985
Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Florida
Collaborators
Prana Therapeutics
Condition
Breast Cancer
Intervention
Epidiferphane
Why stopped
institutional conflict of interest
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-13